ABVC BioPharma, Inc. Accounts Receivable
ABVC BioPharma, Inc. (ECOC) had Accounts Receivable of $1.53 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2025-04-15
- 2024-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.53K.
- 2024-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.53K.
- 2024-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.53K.
- 2023-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.53K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2024-09-30 | $1.53K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.53K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.53K 10-Q · filed 2024-05-17 | |
| 2023-12-31 | $1.53K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.53K 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $12.36K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $124.13K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $98.33K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $47.68K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $289.47K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $281.20K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $280.69K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $331.37K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $297.02K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $392.53K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $159.71K 10-K · filed 2022-03-31 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $2.26K 10-Q · filed 2015-06-05 | $0.00 10-Q · filed 2015-05-15 |
| 2014-12-31 | $0.00 10-Q · filed 2015-04-17 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-08-19 | |
| 2014-06-30 | $1.24K 10-Q · filed 2015-04-17 | |
| 2014-03-31 | $1.24K 10-Q · filed 2015-04-17 | |
| 2013-12-31 | $1.24K 10-Q · filed 2015-04-17 | |
| 2013-09-30 | $1.24K 10-Q · filed 2015-04-17 | |
| 2013-06-30 | $1.24K 10-Q · filed 2015-04-16 | |
| 2013-03-31 | $1.24K 10-Q · filed 2015-04-16 | |
| 2012-12-31 | $1.24K 10-Q · filed 2015-04-16 | |
| 2012-09-30 | $0.00 10-Q · filed 2015-04-16 |